New Market Study Published: Kuwait Pharmaceuticals & Healthcare Report Q4 2012
BMI View: In BMI's Pharmaceuticals Risk/Reward Ratings (RRR) table for Q412, Kuwait remains in second position, trailing the United Arab Emirates (UAE). Its risks profile is stronger than its rewards, which are squeezed by the small market size and political instability that may stall the reform of its healthcare system. Nevertheless, healthcare expenditure growth will continue to be driven by the expansion of facilities as well as by the country's disease profile, with Kuwaitis, for example, suffering one of the...
View full press release